Sirigen

About Sirigen

Sirigen specializes in developing high sensitivity fluorescence materials designed to enhance the performance of diagnostic and life science assays. The company's technology is platform agnostic, meaning it can be integrated with a wide range of existing diagnostic protocols and instruments. Sirigen's materials are used in both molecular and immunoassays, providing superior sensitivity and enabling the detection of more markers, which is crucial for the early investigation and management of diseases such as HIV and leukemia. The company serves clients in the diagnostic and life science sectors, offering customizable solutions that deliver competitive advantages and improved profitability. Sirigen's business model revolves around the sale of its proprietary materials and technologies to diagnostic companies and research institutions. Revenue is generated through direct sales and licensing agreements. The company's innovative products, such as the Brilliant Violet family of fluorescent dyes, are designed to deliver high performance and rapid results, supporting near-patient testing with low-cost, handheld devices.